SCHEMBL4551486

SCHEMBL4551486

CCOc1cc(CN(c2ccc(S(C)(=O)=O)cn2)C2CCNCC2)cc(OCC)c1F

nearest known ligand 0.35

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 2/20 0.35
SLC6A2 P23975 7/20 0.34
SLC6A4 P31645 7/20 0.34
JAK2 O60674 2/20 0.34
SLC6A3 Q01959 4/20 0.34
KCNH2 Q12809 4/20 0.33
HTT P42858 2/20 0.33
HTR6 P50406 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
HSD17B10 Q99714 1/20 0.33
MAPT P10636 1/20 0.33
ALOX5AP P20292 3/20 0.33
FEN1 P39748 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3978560 0.83 RXRA (0.42) MAPT
SCHEMBL3972380 0.83 SLC6A2 (0.39) SLC6A2SLC6A4JAK2SLC6A3HTR6
SCHEMBL3973958 0.82 SSTR5 (0.40) SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL4704418 0.79 SLC6A2 (0.41) SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL3979077 0.77 SSTR5 (0.40) KCNH2
SCHEMBL3970171 0.77 HTR2A (0.36) SLC6A2SLC6A4SLC6A3KCNH2ALDH1A1
SCHEMBL3971706 0.76 SLC6A2 (0.35) SLC6A2SLC6A4JAK2SLC6A3KCNH2
SCHEMBL3970388 0.75 SLC6A2 (0.39) SLC6A2SLC6A4SLC6A3HTR6
SCHEMBL3972445 0.75 SSTR5 (0.40) SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL3979779 0.74 RXRA (0.41) SLC6A2SLC6A4SLC6A3KCNH2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2054385-A2 PHENYL, PYRIDINE AND QUINOLINE DERIVATIVES F. Hoffmann-Roche AG (CH) 2009-05-06 EP disclosed
WO-2008019967-A2 PHENYL, PYRIDINE AND QUINOLINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2008-02-21 WO disclosed